¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"last normal menstrual period"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • normal pressure
    Á¤»ó¾Ð, Ç¥ÁؾÐ
  • normal pressure hydrocephalus
    Á¤»ó¾Ð¹°³úÁõ, Á¤»ó¾Ð¼öµÎÁõ
  • normal retinal correspondence
    Á¤»ó¸Á¸·´ëÀÀ
  • normal saline
    »ý¸®½Ä¿°¼ö
  • normal saline solution
    »ý¸®½Ä¿°¼ö
  • normal serum albumin
    Á¤»óÇ÷û¾ËºÎ¹Î
  • normal singleton pregnancy
    Á¤»ó¿Üµ¿ÀÓ½Å
  • normal sinus rhythm
    Á¤»ó±¼¸®µë, Á¤»óµ¿¸®µë
  • normal state
    Á¤»ó»óÅÂ
  • normal temperature
    Á¤»óü¿Â
  • normal tension glaucoma
    Á¤»ó¾È¾Ð³ì³»Àå
  • normal value
    Á¤»óÄ¡, Á¤»ó°ª
  • age-period cohort analysis
    ¿¬·É±â°£ÄÚȣƮºÐ¼®
  • absolute refractory period
    Àý´ëºÒÀÀ±â
  • communicable period
    Àü¿°±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • normal
    Á¤»ó-, ³ë¸£¸»
  • normal opsonin
    Á¤»ó¿É¼Ò´Ñ
  • normal pressure
    Á¤»ó¾Ð, Ç¥ÁؾÐ
  • normal state
    Á¤»ó»óÅÂ
  • normal value
    Á¤»óÄ¡
  • normal oxidizing solution
    ±ÔÁ¤»êÈ­¾×
  • normal saline solution
    (¢¡physiological salt) »ý¸®½Ä¿°¼ö
  • absolute refractory period
    Àý´ëºÒÀÀ±â
  • age-period cohort analysis
    ¿¬·É±â°£ÄÚȣƮºÐ¼®
  • childbearing period
    ÀӽŰ¡´É±â°£
  • communicable period
    Àü¿°±â
  • definitive fetal period
    žƿϼº±â
  • ejection period
    ¹ÚÃâ±â
  • embryonic period
    ¹è¾Æ±â
  • extrinsic incubation period
    ¿ÜÀẹ±â, ¹Ù±ùÀẹ±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pulse repetition period
    ÆÞ½º ¹Ýº¹ ÁÖ±â
  • quarantine period
    °Ë¿ª±â°£.
  • reaction period
    ¹ÝÀÀ±â(ÚãëëÑ¢).
  • relative refractory period
    »ó´ë(Àû) ºÒÀÀ±â(ßÓÓßîÜÝÕëëÑ¢).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • common opsonin =normal o.
    Á¤»ó(ïáßÈ)¿É¼Ò´Ñ.
  • flora, normal
    Á¤»ó¼¼±ÕÃÑ
  • full term normal delivery =FTND
    ¸¸±âÁ¤»óºÐ¸¸(ػѢïáßÈÝÂØ´).
  • full term normal vaginal delivery
    ¸¸±âÁ¤»ó°æÁú½ÄºÐ¸¸.
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
  • hypothetical normal occlusion
    °¡»óÁ¤»ó±³ÇÕ(Ê£ßÌïáßÈÎáùê).
  • individual normal occlusion
    °³¼ºÁ¤»ó±³ÇÕ (ËÁàõïáßÈÎáùê).
  • logarithmic normal distribution
    ·Î±×Á¤±ÔºÐÆ÷, ´ë¼öÁ¤±ÔºÐÆ÷(ÊÙËøË»ËÓ̰).
  • neutral occlusion =normal o.
    Á¤»ó±³ÇÕ.
  • normal
    1.Á¤»óÀÇ 2.³óµµÀÇ ´ÜÀ§,1±×·¥´ç·®/1000ml
  • normal bacterial flora
    Á¤»ó¼¼±ÕÃÑ.
  • normal curve
    Á¤±Ô°î¼±(ËøË»Ë­ËÛ).
  • normal diet
    º¸Åë½Ä(ÜÅ÷×ãÝ).
  • normal dispersion
    Á¤»óºÐ»ê(~ËÓË×).
  • normal distribution
    Á¤±ÔºÐÆ÷(ËøË»ËÓ̰).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Intermitotic period
    À¯»çºÐ¿­»çÀ̱â
    [¿¾ ¿ë¾î] °£±â
  • Uterine period
    Àڱñâ
    [¿¾ ¿ë¾î] Àڱñâ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
IP icterus praecox; imaging plate; immune precipitate; immunoblastic plasma; immunoperoxidase technique...
FMP faculty mentorship program; first menstrual period; fructose monophosphate
MP macrophage; matrix protein; mean pressure; melphalan and prednisone; melting point; membrane potenti...
PMP pain management program; patient management program; patient medication profile; peripheral myelin p...
NBS N-bromosuccinimide; National Bureau of Standards; neuroblastoma supressor; nevoid basal cell carcino...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ERP Effective refractory period
HP Heart Period
HPV Heart period variability
IRP Isovolumic relaxation period
PER PERIOD
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • incubation period
    Àẹ±â, Àẹ ±â°£, º¸¿Â ±â°£, ¹è¾ç ±â°£
    1. ¹ßÀ°¿¡ ÇÊ¿äÇÑ ±â°£. 2. Àẹ±â. ¿øÀÎ ±ÕÀÌ Ã¼³»¿¡ ħÀÔÇÑ ¼ø°£ºÎÅÍ ½ÃÀÛÇÏ¿© ÁúȯÀÇ ÃÖÃÊÀÇ Áõ»óÀÌ ³ªÅ¸³¯ ¶§±îÁöÀÇ ±â°£.
  • isovolumetric relaxation period
    µî¿ë¼º À̿ϱâ
  • juvenile period
    À¯³â±â
  • latent period
    Àẹ±â, Àẹ½Ã, ÀáÀڱؽÃ, Àẹ ±â°£
    ¿Ü°ü»ó ºÒȰ¼ºÈ­ µÈ ±â°£. Á¶Á÷ÀÌ À¯ÇØ ¹°Áú¿¡ ³ëÃâ µÈ °Í°ú ¹ÝÀÀÀÌ ÀϾ±â±îÁöÀÇ »çÀÌ ¶Ç´Â Áï°¢ÀûÀÎ Àڱذú ¹ÝÀÀÀÇ ½ÃÀÛ »çÀÌÀÇ ±â°£.
  • maturation period
    ¼º¼÷±â
  • multiplication period
    Áõ½Ä±â
  • neonatal period
    ½Å»ý¾Æ±â
  • oedipal period
    ¿¡µðǪ½º ½Ã±â
  • perinatal period
    Ãâ»ý ÀüÈıâ
  • period effect
    ±â°£ È¿°ú
  • period of hospitalization
    ÀÔ¿ø ±â°£
  • period of labial fissure
    ÀÔ¼ú Æ´»õ±â
  • period of menstruation
    ¿ù°æ±â
  • period of newborn
    ½Å»ý¾Æ±â
  • period of the puberty
    »çÃá±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
normal occlusion That arrangement of teeth and their supporting structure which is usually found in health and which approaches an ideal or standard arrangement.
Synonym: normal bite.
Synonym: neutral occlusion.
(05 Mar 2000)
normal opsonin That normally present in the blood, i.e., without stimulation by a known, specific antigen such as certain complement components; it is relatively thermolabile and reacts with various organisms.
Synonym: common opsonin, thermolabile opsonin.
Specific opsonin, antibodies formed in response to stimulation by a specific antigen, either as a result of an attack of a disease, or injections with a suitably prepared suspension of the specific microorganism.
Synonym: immune opsonin, thermostable opsonin.
(05 Mar 2000)
normal pressure hydrocephalus <neurology> A brain disorder caused by blockage of the flow of cerebrospinal fluid (CSF), with enlargement of the ventricles of the brain (keep the pressure normal) and compression of brain tissue. Brain atrophy is the result. In this condition the CSF is produced normally but not reabsorbed.
Symptom onset is gradual. A key feature is dementia. Treatment is surgical (VP shunt).
(13 Nov 1997)
normal range Normal results can fall outside the normal range. By convention, the normal range is set to cover ninety-five percent (95%) of values from a normal population. Five percent (5%) of normal results therefore fall outside the normal range.
(12 Dec 1998)
normal serum A nonimmune serum, usually with reference to a serum obtained prior to immunization.
(05 Mar 2000)
normal tartrate Tartrate that contains no uncombined acid groups.
(05 Mar 2000)
normal toxin A toxin solution holding exactly 100 lethal doses in 1 ml.
(05 Mar 2000)
normal values A set of laboratory test value's used to characterise apparently healthy individuals; now replaced by reference value's.
(05 Mar 2000)
absolute refractory period The period following excitation when no response is possible regardless of the intensity of the stimulus.
(05 Mar 2000)
alabama period <geology> A period in the American eocene, the lowest in the tertiary age except the lignitic.
Source: Websters Dictionary
(01 Mar 1998)
anaesthesia recovery period The period of emergence from general anaesthesia, where different elements of consciousness return at different rates.
(12 Dec 1998)
Gap1 period The period of the cell cycle after cell division when there is synthesis of RNA and protein; it may last for a few hours in rapidly growing tissue or a lifetime in non-renewing cells such as nerve cells.
Synonym: Gap1 phase, postmitotic phase.
(05 Mar 2000)
Gap2 period The period in the cell cycle when synthesis of DNA is completed but before mitosis begins.
Synonym: Gap2 phase, premitotic phase.
(05 Mar 2000)
masticatory silent period A pause in electromyographic patterns associated with tooth contacts during chewing and biting; a part of the complex feedback mechanism of mandibular control involving receptors in the periodontal ligament and muscles.
(05 Mar 2000)
refractory period <neurology, physiology> most commonly used in reference to the interval (typically 1ms) after the passage of an action potential during which an axon is incapable of responding to another. This is caused by inactivation of the sodium channels after opening. The maximum frequency at which neurons can fire is thus limited to a few hundred Hertz. An analogous refractory period occurs in individuals of Dictyostelium discoideum, which are insensitive to extracellular cyclic AMP immediately after a pulse of cAMP has been secreted.
The term can be applied to any system where a similar insensitive period follows stimulation.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á